BRAFCOVI
DEAD

Serial Number

87274926

Owner

Array BioPharma Inc.

Attorney

Cynthia Johnson Walden

Filing Date

Dec 20, 2016

Add to watchlist:

No watchlists yet
View on USPTO

BRAFCOVI Trademark

Serial Number: 87274926

BRAFCOVI is a trademark filed by Array BioPharma Inc. on December 20, 2016. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Array BioPharma Inc. (29 trademarks)

Boulder, CO 80301

Entity Type: 03

Trademark Details

Filing Date

December 20, 2016

Registration Date

Not Registered

Published for Opposition

May 30, 2017

Goods & Services

Anti-infectives; Anti-inflammatories; Antibacterial pharmaceuticals; Antibiotics; Antifungal preparations; Antivirals; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for the treatment of heart rhythm disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of kidney diseases; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use; Pharmaceutical products for the prevention and treatment of cancer and tumors; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Mar 2, 2020 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Mar 2, 2020 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 10, 2019 EXRA
SOU EXTENSION 4 GRANTED
Jul 8, 2019 EX4G
SOU EXTENSION 4 FILED
Jul 8, 2019 EXT4
SOU TEAS EXTENSION RECEIVED
Jul 8, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 16, 2019 EXRA
SOU EXTENSION 3 GRANTED
Jan 14, 2019 EX3G
SOU EXTENSION 3 FILED
Jan 14, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Jan 14, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 12, 2018 EXRA
SOU EXTENSION 2 GRANTED
Jul 10, 2018 EX2G
SOU EXTENSION 2 FILED
Jul 10, 2018 EXT2
SOU TEAS EXTENSION RECEIVED
Jul 10, 2018 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jan 10, 2018 EXRA
SOU EXTENSION 1 GRANTED
Jan 8, 2018 EX1G
SOU EXTENSION 1 FILED
Jan 8, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Jan 8, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 25, 2017 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 30, 2017 NPUB
PUBLISHED FOR OPPOSITION
May 30, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 10, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2017 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 21, 2017 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 21, 2017 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 21, 2017 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 21, 2017 CNEA
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Mar 21, 2017 ZZZX
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 21, 2017 CNSA
ASSIGNED TO EXAMINER
Mar 21, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 29, 2016 NWOS
NEW APPLICATION ENTERED
Dec 23, 2016 NWAP